Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABA A ) Receptor Modulators

Marco Stadler, Serena Monticelli, Thomas Seidel, Denise Luger, Isabella Salzer, Stefan Boehm, Wolfgang Holzer, Christoph Schwarzer, Ernst Urban, Sophia Khom, Thierry Langer, Vittorio Pace, Steffen Hering

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)317-341
    Number of pages25
    JournalJournal of Medicinal Chemistry
    Volume62
    Issue number1
    DOIs
    Publication statusPublished - 1 Oct 2019

    Funding

    Financial support to S.H. was provided by the Austrian Science Fund (FWF). M.S. is a fellow of the FWF-funded doctoral program “Molecular Drug Targets” W1232. T.L., S.B., and S.H. receive support from the interuniversity cluster project “Novel scaffolds for improved antiepileptic drugs” financed by the University of Vienna and the Medical University of Vienna. We thank Dr. Marcel van der Heyden for critical reading of the manuscript.

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry
    • 301206 Pharmacology

    Keywords

    • BENZODIAZEPINE BINDING-SITE
    • VALERENIC ACID
    • 3D PHARMACOPHORE
    • INTERNATIONAL UNION
    • EFFICIENT SYNTHESIS
    • LIGAND RECOGNITION
    • NATURAL-PRODUCTS
    • SUBTYPES
    • ANTICONVULSANT
    • CHANNELS

    Fingerprint

    Dive into the research topics of 'Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABA A ) Receptor Modulators'. Together they form a unique fingerprint.

    Cite this